Use of fuse nicotinamides to promote neurogenesis
US7560553B1 · kind B1 · utility
8Cited by
28References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 17, 2008 |
| Grant date | Jul 14, 2009 |
| Priority date | — |
| Expiry date | Mar 17, 2028 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/6896
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a group of compounds found to increase the number of neurons derived from stem cells for use as a therapeutic agent in neurological conditions or diseases. In one embodiment of the present invention, the compounds are used to detect the mechanism by which the number of neurons is increased.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.